Big Gains With Denosumab in Osteoporosis a Risk for Later Decline

Post-hoc analysis of DAPS study shows those who had greatest gains in BMD on denosumab were more likely to have losses when taking a bisphosphonate thereafter.
Medscape Medical News …read more